Posted in | News | Solar Energy

Quantum Solar Power to Develop Revolutionary Solar Cell Technology

Quantum Solar Power is developing a revolutionary solar cell technology, which will help reduce the application of rare elements by the solar power industry.

Thin-film photovoltaics, though not as efficient as silicon PV, are being rapidly tapped into by the solar cell markets because of their lower manufacturing costs. Only nanometers thick, the thin-film photovoltaics are slender layers of PV material implanted on a substrate. Leading thin-film devices are based upon CIGS (Copper indium gallium selenide) and CdTe (Cadmium Telluride) technologies that employ rare elements such as indium, tellurium and gallium, which are critical to the production of thin-film photovoltaics but are globally very scarce.

Ten terawatts of electricity is consumed globally. However, with the limited resources of the rare elements, it will not be possible to replace power generated by fossil fuels by scaling the production of the thin-film PV solar power. Quantum is of the opinion that the Next Generation Device (NGD) technology can provide cost-effective solar cells with higher efficiency, without tapping into rare elements.

Dr. Andras Pattantyus-Abraham, the chief technology officer of Quantum, is of the opinion that Quantum’s patent-pending technology will enable photovoltaics to scale limitlessly to the terawatt-scale, which cannot be possible with continued dependence and limited source of rare elements. This has been achieved by eliminating the semiconductor layer as the main absorber of photons. Research shows that indium will be available for less than10 years. Additionally, electronics like the flat panel LCD TV also employs thin-film PV. CEO of Quantum, Daryl Ehrmantraut stated that the barrier between fossil fuels and solar power can finally be broken.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.